 | • レポートコード：MRC2-11QY02530 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗凝固薬のグローバル市場について調査・分析したレポートです。種類別（新規経口抗凝固薬（NOAC）、ワルファリン（VKA）、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗凝固薬の競争状況、市場シェア ・世界の抗凝固薬市場：種類別市場規模 2015年-2020年（新規経口抗凝固薬（NOAC）、ワルファリン（VKA）、その他） ・世界の抗凝固薬市場：種類別市場規模予測 2021年-2026年（新規経口抗凝固薬（NOAC）、ワルファリン（VKA）、その他） ・世界の抗凝固薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の抗凝固薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の抗凝固薬市場分析：米国、カナダ ・ヨーロッパの抗凝固薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗凝固薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗凝固薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗凝固薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：C. H. Boehringer Sohn (Germany)、Bristol-Myers Squibb (US)、Johnson & Johnson (US)、Pfizer (US)、Daiichi Sankyo (Japan)、Portola Pharmaceuticals (US)、Roche (Switzerland)、Abbott (US)、Siemens (Germany)、Alere (US)、CoaguSense (US) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Anticoagulants Drug Market
The global Anticoagulants Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anticoagulants Drug Scope and Market Size
Anticoagulants Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anticoagulants Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anticoagulants Drug market is segmented into
Novel Oral Anticoagulants (NOACs)
Warfarin (VKA)
Others
Segment by Application, the Anticoagulants Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Anticoagulants Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anticoagulants Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anticoagulants Drug Market Share Analysis
Anticoagulants Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anticoagulants Drug business, the date to enter into the Anticoagulants Drug market, Anticoagulants Drug product introduction, recent developments, etc.
The major vendors covered:
C. H. Boehringer Sohn (Germany)
Bristol-Myers Squibb (US)
Johnson & Johnson (US)
Pfizer (US)
Daiichi Sankyo (Japan)
Portola Pharmaceuticals (US)
Roche (Switzerland)
Abbott (US)
Siemens (Germany)
Alere (US)
CoaguSense (US)
1 Study Coverage
1.1 Anticoagulants Drug Product Introduction
1.2 Market Segments
1.3 Key Anticoagulants Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anticoagulants Drug Market Size Growth Rate by Type
1.4.2 Novel Oral Anticoagulants (NOACs)
1.4.3 Warfarin (VKA)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Anticoagulants Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anticoagulants Drug Market Size, Estimates and Forecasts
2.1.1 Global Anticoagulants Drug Revenue 2015-2026
2.1.2 Global Anticoagulants Drug Sales 2015-2026
2.2 Global Anticoagulants Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anticoagulants Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anticoagulants Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anticoagulants Drug Competitor Landscape by Players
3.1 Anticoagulants Drug Sales by Manufacturers
3.1.1 Anticoagulants Drug Sales by Manufacturers (2015-2020)
3.1.2 Anticoagulants Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Anticoagulants Drug Revenue by Manufacturers
3.2.1 Anticoagulants Drug Revenue by Manufacturers (2015-2020)
3.2.2 Anticoagulants Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anticoagulants Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anticoagulants Drug Revenue in 2019
3.2.5 Global Anticoagulants Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anticoagulants Drug Price by Manufacturers
3.4 Anticoagulants Drug Manufacturing Base Distribution, Product Types
3.4.1 Anticoagulants Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anticoagulants Drug Product Type
3.4.3 Date of International Manufacturers Enter into Anticoagulants Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anticoagulants Drug Market Size by Type (2015-2020)
4.1.1 Global Anticoagulants Drug Sales by Type (2015-2020)
4.1.2 Global Anticoagulants Drug Revenue by Type (2015-2020)
4.1.3 Anticoagulants Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anticoagulants Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Anticoagulants Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Anticoagulants Drug Revenue Forecast by Type (2021-2026)
4.2.3 Anticoagulants Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anticoagulants Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anticoagulants Drug Market Size by Application (2015-2020)
5.1.1 Global Anticoagulants Drug Sales by Application (2015-2020)
5.1.2 Global Anticoagulants Drug Revenue by Application (2015-2020)
5.1.3 Anticoagulants Drug Price by Application (2015-2020)
5.2 Anticoagulants Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Anticoagulants Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Anticoagulants Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Anticoagulants Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anticoagulants Drug by Country
6.1.1 North America Anticoagulants Drug Sales by Country
6.1.2 North America Anticoagulants Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anticoagulants Drug Market Facts & Figures by Type
6.3 North America Anticoagulants Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Anticoagulants Drug by Country
7.1.1 Europe Anticoagulants Drug Sales by Country
7.1.2 Europe Anticoagulants Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anticoagulants Drug Market Facts & Figures by Type
7.3 Europe Anticoagulants Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anticoagulants Drug by Region
8.1.1 Asia Pacific Anticoagulants Drug Sales by Region
8.1.2 Asia Pacific Anticoagulants Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anticoagulants Drug Market Facts & Figures by Type
8.3 Asia Pacific Anticoagulants Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anticoagulants Drug by Country
9.1.1 Latin America Anticoagulants Drug Sales by Country
9.1.2 Latin America Anticoagulants Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anticoagulants Drug Market Facts & Figures by Type
9.3 Central & South America Anticoagulants Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anticoagulants Drug by Country
10.1.1 Middle East and Africa Anticoagulants Drug Sales by Country
10.1.2 Middle East and Africa Anticoagulants Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anticoagulants Drug Market Facts & Figures by Type
10.3 Middle East and Africa Anticoagulants Drug Market Facts & Figures by Application
11 Company Profiles
11.1 C. H. Boehringer Sohn (Germany)
11.1.1 C. H. Boehringer Sohn (Germany) Corporation Information
11.1.2 C. H. Boehringer Sohn (Germany) Description and Business Overview
11.1.3 C. H. Boehringer Sohn (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Products Offered
11.1.5 C. H. Boehringer Sohn (Germany) Related Developments
11.2 Bristol-Myers Squibb (US)
11.2.1 Bristol-Myers Squibb (US) Corporation Information
11.2.2 Bristol-Myers Squibb (US) Description and Business Overview
11.2.3 Bristol-Myers Squibb (US) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb (US) Anticoagulants Drug Products Offered
11.2.5 Bristol-Myers Squibb (US) Related Developments
11.3 Johnson & Johnson (US)
11.3.1 Johnson & Johnson (US) Corporation Information
11.3.2 Johnson & Johnson (US) Description and Business Overview
11.3.3 Johnson & Johnson (US) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson (US) Anticoagulants Drug Products Offered
11.3.5 Johnson & Johnson (US) Related Developments
11.4 Pfizer (US)
11.4.1 Pfizer (US) Corporation Information
11.4.2 Pfizer (US) Description and Business Overview
11.4.3 Pfizer (US) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer (US) Anticoagulants Drug Products Offered
11.4.5 Pfizer (US) Related Developments
11.5 Daiichi Sankyo (Japan)
11.5.1 Daiichi Sankyo (Japan) Corporation Information
11.5.2 Daiichi Sankyo (Japan) Description and Business Overview
11.5.3 Daiichi Sankyo (Japan) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Daiichi Sankyo (Japan) Anticoagulants Drug Products Offered
11.5.5 Daiichi Sankyo (Japan) Related Developments
11.6 Portola Pharmaceuticals (US)
11.6.1 Portola Pharmaceuticals (US) Corporation Information
11.6.2 Portola Pharmaceuticals (US) Description and Business Overview
11.6.3 Portola Pharmaceuticals (US) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Portola Pharmaceuticals (US) Anticoagulants Drug Products Offered
11.6.5 Portola Pharmaceuticals (US) Related Developments
11.7 Roche (Switzerland)
11.7.1 Roche (Switzerland) Corporation Information
11.7.2 Roche (Switzerland) Description and Business Overview
11.7.3 Roche (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Roche (Switzerland) Anticoagulants Drug Products Offered
11.7.5 Roche (Switzerland) Related Developments
11.8 Abbott (US)
11.8.1 Abbott (US) Corporation Information
11.8.2 Abbott (US) Description and Business Overview
11.8.3 Abbott (US) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Abbott (US) Anticoagulants Drug Products Offered
11.8.5 Abbott (US) Related Developments
11.9 Siemens (Germany)
11.9.1 Siemens (Germany) Corporation Information
11.9.2 Siemens (Germany) Description and Business Overview
11.9.3 Siemens (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Siemens (Germany) Anticoagulants Drug Products Offered
11.9.5 Siemens (Germany) Related Developments
11.10 Alere (US)
11.10.1 Alere (US) Corporation Information
11.10.2 Alere (US) Description and Business Overview
11.10.3 Alere (US) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Alere (US) Anticoagulants Drug Products Offered
11.10.5 Alere (US) Related Developments
11.1 C. H. Boehringer Sohn (Germany)
11.1.1 C. H. Boehringer Sohn (Germany) Corporation Information
11.1.2 C. H. Boehringer Sohn (Germany) Description and Business Overview
11.1.3 C. H. Boehringer Sohn (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 C. H. Boehringer Sohn (Germany) Anticoagulants Drug Products Offered
11.1.5 C. H. Boehringer Sohn (Germany) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anticoagulants Drug Market Estimates and Projections by Region
12.1.1 Global Anticoagulants Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Anticoagulants Drug Revenue Forecast by Regions 2021-2026
12.2 North America Anticoagulants Drug Market Size Forecast (2021-2026)
12.2.1 North America: Anticoagulants Drug Sales Forecast (2021-2026)
12.2.2 North America: Anticoagulants Drug Revenue Forecast (2021-2026)
12.2.3 North America: Anticoagulants Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Anticoagulants Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Anticoagulants Drug Sales Forecast (2021-2026)
12.3.2 Europe: Anticoagulants Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Anticoagulants Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anticoagulants Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anticoagulants Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anticoagulants Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anticoagulants Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Anticoagulants Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Anticoagulants Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Anticoagulants Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Anticoagulants Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anticoagulants Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anticoagulants Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anticoagulants Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anticoagulants Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anticoagulants Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anticoagulants Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anticoagulants Drug Market Segments
Table 2. Ranking of Global Top Anticoagulants Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anticoagulants Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Novel Oral Anticoagulants (NOACs)
Table 5. Major Manufacturers of Warfarin (VKA)
Table 6. Major Manufacturers of Others
Table 7. Global Anticoagulants Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global Anticoagulants Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global Anticoagulants Drug Sales by Regions 2015-2020 (K Pcs)
Table 10. Global Anticoagulants Drug Sales Market Share by Regions (2015-2020)
Table 11. Global Anticoagulants Drug Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Anticoagulants Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 13. Global Anticoagulants Drug Sales Share by Manufacturers (2015-2020)
Table 14. Global Anticoagulants Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Anticoagulants Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulants Drug as of 2019)
Table 16. Anticoagulants Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Anticoagulants Drug Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Anticoagulants Drug Price (2015-2020) (USD/Pcs)
Table 19. Anticoagulants Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Anticoagulants Drug Product Type
Table 21. Date of International Manufacturers Enter into Anticoagulants Drug Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Anticoagulants Drug Sales by Type (2015-2020) (K Pcs)
Table 24. Global Anticoagulants Drug Sales Share by Type (2015-2020)
Table 25. Global Anticoagulants Drug Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Anticoagulants Drug Revenue Share by Type (2015-2020)
Table 27. Anticoagulants Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 28. Global Anticoagulants Drug Sales by Application (2015-2020) (K Pcs)
Table 29. Global Anticoagulants Drug Sales Share by Application (2015-2020)
Table 30. North America Anticoagulants Drug Sales by Country (2015-2020) (K Pcs)
Table 31. North America Anticoagulants Drug Sales Market Share by Country (2015-2020)
Table 32. North America Anticoagulants Drug Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Anticoagulants Drug Revenue Market Share by Country (2015-2020)
Table 34. North America Anticoagulants Drug Sales by Type (2015-2020) (K Pcs)
Table 35. North America Anticoagulants Drug Sales Market Share by Type (2015-2020)
Table 36. North America Anticoagulants Drug Sales by Application (2015-2020) (K Pcs)
Table 37. North America Anticoagulants Drug Sales Market Share by Application (2015-2020)
Table 38. Europe Anticoagulants Drug Sales by Country (2015-2020) (K Pcs)
Table 39. Europe Anticoagulants Drug Sales Market Share by Country (2015-2020)
Table 40. Europe Anticoagulants Drug Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Anticoagulants Drug Revenue Market Share by Country (2015-2020)
Table 42. Europe Anticoagulants Drug Sales by Type (2015-2020) (K Pcs)
Table 43. Europe Anticoagulants Drug Sales Market Share by Type (2015-2020)
Table 44. Europe Anticoagulants Drug Sales by Application (2015-2020) (K Pcs)
Table 45. Europe Anticoagulants Drug Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Anticoagulants Drug Sales by Region (2015-2020) (K Pcs)
Table 47. Asia Pacific Anticoagulants Drug Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Anticoagulants Drug Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Anticoagulants Drug Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Anticoagulants Drug Sales by Type (2015-2020) (K Pcs)
Table 51. Asia Pacific Anticoagulants Drug Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Anticoagulants Drug Sales by Application (2015-2020) (K Pcs)
Table 53. Asia Pacific Anticoagulants Drug Sales Market Share by Application (2015-2020)
Table 54. Latin America Anticoagulants Drug Sales by Country (2015-2020) (K Pcs)
Table 55. Latin America Anticoagulants Drug Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Anticoagulants Drug Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Anticoagulants Drug Revenue Market Share by Country (2015-2020)
Table 58. Latin America Anticoagulants Drug Sales by Type (2015-2020) (K Pcs)
Table 59. Latin America Anticoagulants Drug Sales Market Share by Type (2015-2020)
Table 60. Latin America Anticoagulants Drug Sales by Application (2015-2020) (K Pcs)
Table 61. Latin America Anticoagulants Drug Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Anticoagulants Drug Sales by Country (2015-2020) (K Pcs)
Table 63. Middle East and Africa Anticoagulants Drug Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Anticoagulants Drug Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Anticoagulants Drug Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anticoagulants Drug Sales by Type (2015-2020) (K Pcs)
Table 67. Middle East and Africa Anticoagulants Drug Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Anticoagulants Drug Sales by Application (2015-2020) (K Pcs)
Table 69. Middle East and Africa Anticoagulants Drug Sales Market Share by Application (2015-2020)
Table 70. C. H. Boehringer Sohn (Germany) Corporation Information
Table 71. C. H. Boehringer Sohn (Germany) Description and Major Businesses
Table 72. C. H. Boehringer Sohn (Germany) Anticoagulants Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 73. C. H. Boehringer Sohn (Germany) Product
Table 74. C. H. Boehringer Sohn (Germany) Recent Development
Table 75. Bristol-Myers Squibb (US) Corporation Information
Table 76. Bristol-Myers Squibb (US) Description and Major Businesses
Table 77. Bristol-Myers Squibb (US) Anticoagulants Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Bristol-Myers Squibb (US) Product
Table 79. Bristol-Myers Squibb (US) Recent Development
Table 80. Johnson & Johnson (US) Corporation Information
Table 81. Johnson & Johnson (US) Description and Major Businesses
Table 82. Johnson & Johnson (US) Anticoagulants Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson (US) Product
Table 84. Johnson & Johnson (US) Recent Development
Table 85. Pfizer (US) Corporation Information
Table 86. Pfizer (US) Description and Major Businesses
Table 87. Pfizer (US) Anticoagulants Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Pfizer (US) Product
Table 89. Pfizer (US) Recent Development
Table 90. Daiichi Sankyo (Japan) Corporation Information
Table 91. Daiichi Sankyo (Japan) Description and Major Businesses
Table 92. Daiichi Sankyo (Japan) Anticoagulants Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Daiichi Sankyo (Japan) Product
Table 94. Daiichi Sankyo (Japan) Recent Development
Table 95. Portola Pharmaceuticals (US) Corporation Information
Table 96. Portola Pharmaceuticals (US) Description and Major Businesses
Table 97. Portola Pharmaceuticals (US) Anticoagulants Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Portola Pharmaceuticals (US) Product
Table 99. Portola Pharmaceuticals (US) Recent Development
Table 100. Roche (Switzerland) Corporation Information
Table 101. Roche (Switzerland) Description and Major Businesses
Table 102. Roche (Switzerland) Anticoagulants Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Roche (Switzerland) Product
Table 104. Roche (Switzerland) Recent Development
Table 105. Abbott (US) Corporation Information
Table 106. Abbott (US) Description and Major Businesses
Table 107. Abbott (US) Anticoagulants Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Abbott (US) Product
Table 109. Abbott (US) Recent Development
Table 110. Siemens (Germany) Corporation Information
Table 111. Siemens (Germany) Description and Major Businesses
Table 112. Siemens (Germany) Anticoagulants Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Siemens (Germany) Product
Table 114. Siemens (Germany) Recent Development
Table 115. Alere (US) Corporation Information
Table 116. Alere (US) Description and Major Businesses
Table 117. Alere (US) Anticoagulants Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Alere (US) Product
Table 119. Alere (US) Recent Development
Table 120. CoaguSense (US) Corporation Information
Table 121. CoaguSense (US) Description and Major Businesses
Table 122. CoaguSense (US) Anticoagulants Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. CoaguSense (US) Product
Table 124. CoaguSense (US) Recent Development
Table 125. Global Anticoagulants Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 126. Global Anticoagulants Drug Sales Market Share Forecast by Regions (2021-2026)
Table 127. Global Anticoagulants Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 128. Global Anticoagulants Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 129. North America: Anticoagulants Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. North America: Anticoagulants Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Europe: Anticoagulants Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 132. Europe: Anticoagulants Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Asia Pacific: Anticoagulants Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 134. Asia Pacific: Anticoagulants Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 135. Latin America: Anticoagulants Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 136. Latin America: Anticoagulants Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Middle East and Africa: Anticoagulants Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 138. Middle East and Africa: Anticoagulants Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Anticoagulants Drug Players
Table 143. Anticoagulants Drug Customers List
Table 144. Anticoagulants Drug Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticoagulants Drug Product Picture
Figure 2. Global Anticoagulants Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Novel Oral Anticoagulants (NOACs) Product Picture
Figure 4. Warfarin (VKA) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Anticoagulants Drug Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Anticoagulants Drug Report Years Considered
Figure 11. Global Anticoagulants Drug Market Size 2015-2026 (US$ Million)
Figure 12. Global Anticoagulants Drug Sales 2015-2026 (K Pcs)
Figure 13. Global Anticoagulants Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Anticoagulants Drug Sales Market Share by Region (2015-2020)
Figure 15. Global Anticoagulants Drug Sales Market Share by Region in 2019
Figure 16. Global Anticoagulants Drug Revenue Market Share by Region (2015-2020)
Figure 17. Global Anticoagulants Drug Revenue Market Share by Region in 2019
Figure 18. Global Anticoagulants Drug Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Anticoagulants Drug Revenue in 2019
Figure 20. Anticoagulants Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Anticoagulants Drug Sales Market Share by Type (2015-2020)
Figure 22. Global Anticoagulants Drug Sales Market Share by Type in 2019
Figure 23. Global Anticoagulants Drug Revenue Market Share by Type (2015-2020)
Figure 24. Global Anticoagulants Drug Revenue Market Share by Type in 2019
Figure 25. Global Anticoagulants Drug Market Share by Price Range (2015-2020)
Figure 26. Global Anticoagulants Drug Sales Market Share by Application (2015-2020)
Figure 27. Global Anticoagulants Drug Sales Market Share by Application in 2019
Figure 28. Global Anticoagulants Drug Revenue Market Share by Application (2015-2020)
Figure 29. Global Anticoagulants Drug Revenue Market Share by Application in 2019
Figure 30. North America Anticoagulants Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 31. North America Anticoagulants Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Anticoagulants Drug Sales Market Share by Country in 2019
Figure 33. North America Anticoagulants Drug Revenue Market Share by Country in 2019
Figure 34. U.S. Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 35. U.S. Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. Canada Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Anticoagulants Drug Market Share by Type in 2019
Figure 39. North America Anticoagulants Drug Market Share by Application in 2019
Figure 40. Europe Anticoagulants Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 41. Europe Anticoagulants Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Anticoagulants Drug Sales Market Share by Country in 2019
Figure 43. Europe Anticoagulants Drug Revenue Market Share by Country in 2019
Figure 44. Germany Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Germany Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. France Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. U.K. Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. Italy Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Russia Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Anticoagulants Drug Market Share by Type in 2019
Figure 55. Europe Anticoagulants Drug Market Share by Application in 2019
Figure 56. Asia Pacific Anticoagulants Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 57. Asia Pacific Anticoagulants Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Anticoagulants Drug Sales Market Share by Region in 2019
Figure 59. Asia Pacific Anticoagulants Drug Revenue Market Share by Region in 2019
Figure 60. China Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. China Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Japan Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. South Korea Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. India Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. Australia Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Taiwan Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Indonesia Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Thailand Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Malaysia Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Philippines Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Vietnam Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Anticoagulants Drug Market Share by Type in 2019
Figure 83. Asia Pacific Anticoagulants Drug Market Share by Application in 2019
Figure 84. Latin America Anticoagulants Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 85. Latin America Anticoagulants Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Anticoagulants Drug Sales Market Share by Country in 2019
Figure 87. Latin America Anticoagulants Drug Revenue Market Share by Country in 2019
Figure 88. Mexico Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Mexico Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Brazil Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Argentina Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Anticoagulants Drug Market Share by Type in 2019
Figure 95. Latin America Anticoagulants Drug Market Share by Application in 2019
Figure 96. Middle East and Africa Anticoagulants Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 97. Middle East and Africa Anticoagulants Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Anticoagulants Drug Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Anticoagulants Drug Revenue Market Share by Country in 2019
Figure 100. Turkey Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Turkey Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Saudi Arabia Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Anticoagulants Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. U.A.E Anticoagulants Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Anticoagulants Drug Market Share by Type in 2019
Figure 107. Middle East and Africa Anticoagulants Drug Market Share by Application in 2019
Figure 108. North America Anticoagulants Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 109. North America Anticoagulants Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Anticoagulants Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. Europe Anticoagulants Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Anticoagulants Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Asia Pacific Anticoagulants Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Anticoagulants Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Latin America Anticoagulants Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Anticoagulants Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Middle East and Africa Anticoagulants Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
経口抗凝固剤の世界市場（～2026年） Market Analysis and Insights: Global Oral Anticoagulants Market The global Oral Anticoagulants market size is projected to reach US$ 15640 million by 2026, from US$ 14530 million in 2020, at a CAGR of 7.1%% during 2021-2026. Global Oral Anticoagulants Scope and Market Size Oral Anticoagulants market…- 新規経口抗凝固剤（NOAC）の世界市場（～2026年） Market Analysis and Insights: Global Novel Oral AntiCoagulants (NOAC) Market The global Novel Oral AntiCoagulants (NOAC) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Novel Oral AntiCoagulants (NOAC) Scope and Market…
- 徐放性経口用ドラッグデリバリー技術の世界市場（～2026年） The combination of various technologies helps in rapidly overcoming problems associated with poorly soluble candidates. This is being aided through greater technology sharing through various conferences and symposiums where companies sharing similar thought processes meet and plan eventual outcomes.…
- 小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…
- 大麻薬の世界市場（～2026年） Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana. Market Analysis and Insights: Global Cannabis Drug Market The global Cannabis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…